You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 11, November 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antiemetic Effect of Tetrahydrocannabinol

Compared With Placebo and Prochlorperazine in Chemotherapy-Associated Nausea and Emesis

Leo E. Orr, MD; Joseph F. McKernan, MD; Berit Bloome, RN

Arch Intern Med. 1980;140(11):1431-1433.


Abstract

• Fifty-five patients harboring a variety of neoplasms and previously found to have severe nausea or emesis from antitumor drugs were given antiemetic prophylaxis in a double-blind, randomized, crossover fashion. Tetrahydrocannabinol (THC), prochlorperazine, and placebo were compared. Nausea was absent in 40 of 55 patients receiving THC, eight of 55 patients receiving prochlorperazine, and five of 55 in the placebo group. The antiemetic effect of THC appeared to be more efficacious for cyclophosphamide, fluorouracil, and doxorubicin hydrochloride, and less so for mechlorethamine hydrochloride and the nitrosureas. Tetrahydrocannabinol appears to offer significant control of nausea in most patients and exceeding by far that provided by prochlorperazine.

(Arch Intern Med 140:1431-1433, 1980)



Author Affiliations

From the Medical Oncology Section, Southern California Cancer Center, California Hospital Medical Center, Los Angeles.


Footnotes

Accepted for publication Dec 27, 1979.

Reprint requests to Medical Oncology Section, Southern California Cancer Center, California Hospital Medical Center, 1414 S Hope St, Los Angeles, CA 90015 (Dr Orr).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Tramer et al.
BMJ 2001;323:16-16.
ABSTRACT | FULL TEXT  

Delta-9-Tetrahydrocannabinol in Cancer Chemotherapy: Research Problems and Issues
CAREY et al.
ANN INTERN MED 1983;99:106-114.
ABSTRACT  

Marijuana: Its Health Hazards and Therapeutic Potentials
Council on Scientific Affairs
JAMA 1981;246:1823-1827.
ABSTRACT  

The Control of Chemotherapy-Induced Emesis
SEIGEL and LONGO
ANN INTERN MED 1981;95:352-359.
ABSTRACT  

{Delta}9-Tetrahydrocannabinol in Clinical Oncology
Poster et al.
JAMA 1981;245:2047-2051.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.